CVS Health Reports Strong Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
CVS Health (CVS) PT Raised to $95 at Cantor Fitzgerald
August 4, 2021 12:48 PM EDTCantor Fitzgerald analyst Steven Halper raised the price target on CVS Health (NYSE: CVS) to $95.00 (from $92.00) while maintaining a Overweight rating following earnings.
The analyst commented, ". We reiterate our Overweight rating on CVS shares and increase our price target to $95 from $92. Before the market open on Wednesday, August... More
CVS Health (CVS) Tops Q2 EPS by 36c, Raises FY EPS Guidance
August 4, 2021 6:32 AM EDTCVS Health (NYSE: CVS) reported Q2 EPS of $2.42, $0.36 better than the analyst estimate of $2.06. Revenue for the quarter came in at $72.6 billion versus the consensus estimate of $70.11 billion.
GUIDANCE:
CVS Health sees FY2021 EPS of $7.70-$7.80, versus the consensus... More
